Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Colorectal Cancer Awareness in Turkey

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04020614
Recruitment Status : Recruiting
First Posted : July 16, 2019
Last Update Posted : July 16, 2019
Sponsor:
Collaborators:
Istanbul Training and Researh Hospital
Taksim Training and Research Hospital
Information provided by (Responsible Party):
Cemile Idiz, Istanbul University

Tracking Information
First Submitted Date July 12, 2019
First Posted Date July 16, 2019
Last Update Posted Date July 16, 2019
Actual Study Start Date May 1, 2019
Estimated Primary Completion Date July 31, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: July 15, 2019)
The awareness of patients about colorectal cancer [ Time Frame: 3 months ]
To assess the awareness of patients about colorectal cancer with a survey
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Colorectal Cancer Awareness in Turkey
Official Title Assessment of Colorectal Cancer Awareness in Patients Admitted to the General Surgery Outpatient Clinic
Brief Summary Colorectal cancer is among the most common types of cancer worldwide. Population-based screening programs for breast, cervical, and colorectal cancer have been introduced as part of cancer control in many high-income countries. Population-based cancer screening programs do not exist in most low- and middle-income countries. There are some studies that report the awareness of colorectal cancer in Turkey.
Detailed Description Colorectal cancer is the third most common type of cancer in both men and women. According to World Health Organization data, in 2012, 694 thousand people were thought to be due to colorectal cancer and this number increased to 862 thousand people in 2018. Especially in most low- and middle-income countries where cancers are mainly detected through very-late-stage symptoms and many are not reported. Recent researches may lead to new approaches to early detection and treatment using improved awareness of the symptomatic disease and population-based screening of asymptomatic people. The increasing of colorectal cancer awareness could help early detection of colorectal cancers. In this study, the investigators aimed to determine the level of awareness of colorectal cancer and knowledge about colorectal cancer screenings in patients who applied to general surgery outpatients clinic where a colorectal cancer diagnosis was most frequently diagnosed.
Study Type Observational
Study Design Observational Model: Other
Time Perspective: Cross-Sectional
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Patients who apply to the general surgery outpatient clinic with any diseases.
Condition Colorectal Cancer
Intervention Other: Survey
A survey with 13 questions will be applied to the patients
Study Groups/Cohorts Survey
All of the patients that enrolled in this study will be in this group.
Intervention: Other: Survey
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: July 15, 2019)
500
Original Estimated Enrollment Same as current
Estimated Study Completion Date August 15, 2019
Estimated Primary Completion Date July 31, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Patients who apply to the general surgery outpatients clinic

Exclusion Criteria:

  • Younger than 18 years old
  • Older than 80 years old
  • Mental retardation or other mental illness
  • Refusing to join the study
Sex/Gender
Sexes Eligible for Study: Male
Ages 18 Years to 80 Years   (Adult, Older Adult)
Accepts Healthy Volunteers Not Provided
Contacts
Contact: Cemile Idiz, PhD +905367206668 cemileidiz@gmail.com
Listed Location Countries Turkey
Removed Location Countries  
 
Administrative Information
NCT Number NCT04020614
Other Study ID Numbers Colorectal Cancer
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: Undecided
Plan Description: In case of request individual participant data could be shared with other researchers
Responsible Party Cemile Idiz, Istanbul University
Study Sponsor Istanbul University
Collaborators
  • Istanbul Training and Researh Hospital
  • Taksim Training and Research Hospital
Investigators
Study Director: Coskun Cakir, MD Istanbul Training and Research Hospital
PRS Account Istanbul University
Verification Date July 2019